Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation, with no observed increase in adverse effects.
!--include>…
While the Omicron variant was not in circulation during the Evusheld clinical trials, the company added that it is continuing to collect further data to better understand the implications…
The US Food and Drug Administration has authorized Merck's second anti-viral drug Molnupiravir, revealed sources. The report said that the prescription pill, which can be taken at home, is…
The first recommendation is for the high-risk category of people who are not vaccinated, immune suppressed, and older COVID-19 patients. For these patients, the combination of imdevimab…
By PTI
WASHINGTON: Scientists have identified a novel target for a drug that can treat the SARS-CoV-2 virus, which causes COVID-19, and also help tackle a future…